Assessing the Effect of Haridru twak in the management of Vyanga (Melasma)

A Comparative Pharmacognostical and Exploratory Study of Haridru (Adina cordifolia Benth. and Hook f.) twak and Jatiphal(Myristica fragrance Houtt.) in the management of Vyanga(melasma) - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069476

Enrollment

Registered

2024-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting Vyanga as clinical features according to Sushruta Samhita. 2. Patients of either sex. 3. Patients of age between 16 - 45 years.

Exclusion criteria

Exclusion criteria: 1. Age less than 16 years and more than 45 years. 2. Patient with present and past history of any skin disease i.e. psoriasis, eczema etc. 3. Vyanga [Hyper pigmentation] caused due to any systemic disease like Cushing syndrome, Addison disease etc. 4. Vyanga [Hyper pigmentation] present since birth. 5. Vyanga [Hyper pigmentation] caused by Tumor like malignant melanoma. 6. History of hypersensitivity. 7. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
changes in 1.MASI ( MELASMA AREA SEVERITY INDEX) SCORE 2. COLOR GRADING SCALETimepoint: 45 days	—

Secondary

Measure	Time frame
CHANGES IN 1. CBC , ESR 2. URINE ROUTINE 3. PHOTOGRAPHY OF THE AFFECTED PARTTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Manoj Adlakha

post graduate institute of ayurveda DSRRAU jodhpur

shivalikameena1190@gmail.com8949363929

Outcome results